Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000880715 | SCV001023834 | benign | not provided | 2023-08-04 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000880715 | SCV001475889 | uncertain significance | not provided | 2020-02-26 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000880715 | SCV001820496 | likely benign | not provided | 2021-03-08 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000880715 | SCV002047819 | likely benign | not provided | 2021-03-09 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002536823 | SCV003659259 | likely benign | Inborn genetic diseases | 2022-04-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004735858 | SCV005351609 | likely benign | HSPG2-related disorder | 2024-05-17 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |